Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
‘Inoculation’ helps people spot political deepfakes, study finds - 2Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
- 3My daughter is in the #1 movie in the country. She still has to finish her math homework.
- 4IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- 5'Sex and the City' star Kim Cattrall marries longtime partner Russell Thomas in intimate London wedding
- Native artists in Texas and Mexico shared their vision of the universe for 4,000 years, ancient murals suggest
- Trump administration plan to reduce access to some student loans angers nurses, health care groups
- Finding Ideal Date Spots for Two or three Encounters
- The most effective method to Go with Informed Choices on Vehicle Leases
- 10 Hints and Deceives to Expand Cell Phone Information Use: Capitalize on Your Information
- Lucrative Positions in the Advancing Position Market of 2024
- In blow to Lula, Brazil Congress revives controversial environmental bill
- 5 Christmas movies to stream for less with this Paramount+ Black Friday deal
- It's time for Artemis II to break Apollo 13's distance record. What to know about the moon flyby
